Nature Communications, 2022 · DOI: https://doi.org/10.1038/s41467-022-30119-8 · Published: May 6, 2022
This study investigates the role of miR-17, a small RNA molecule, in maintaining healthy cartilage and protecting against osteoarthritis (OA). The researchers found that miR-17 levels are reduced in OA cartilage, contributing to disease progression. They showed that increasing miR-17 levels, either by directly adding it or by stimulating its production with a growth factor called GDF-5, can prevent OA by targeting enzymes that break down cartilage. The study also identified different types of cells in cartilage and found that miR-17 helps maintain a balance between cartilage breakdown and repair, potentially by controlling a protein called HIF-1α.
MiR-17 could be a potential drug target for OA. Supplementation of miR-17 might be a potent therapeutic approach for OA as well as prevention of cartilage aging.
The study provides insights into the molecular mechanisms underlying cartilage homeostasis and the role of miR-17 in maintaining this balance.
Identifying different chondrocyte populations and their specific responses to miR-17 could lead to personalized treatment strategies for OA.